
Paclitaxel Boston Biopharma
BB Paclitaxel is approved to be used alone or with other drugs to treat:
• AIDS-related Kaposi’s sarcoma
• Breast cancer
• Non-small cell lung cancer
• Ovarian cancer
Pharmaceutical form: Concentrate for solution for infusion (6 mg/ml)
Strengths:
30 mg/5 ml
100 mg/16.7 ml
150 mg/25 ml
300 mg/ 50 ml
Pack size:
1 vial
